A 24-year study at a single hospital shows a troubling trend: a significant increase in both Group B Streptococcus (GBS) infections and strains resistant to penicillin (PCN-NS GBS). This highlights a growing problem with antimicrobial resistance.

While penicillin is still the main treatment, the rise of PCN-NS GBS—especially in critical samples from the respiratory tract and vagina—underscores the need for routine susceptibility testing and careful antibiotic choices.

The presence of strains resistant to multiple drugs further emphasizes that doctors, infectious disease specialists, and microbiologists must work together to ensure patients get the best care.

Ongoing surveillance and a strong focus on antimicrobial stewardship are crucial to lessen the impact of these resistant GBS strains, particularly for vulnerable patients like newborns, the elderly, and those with weakened immune systems.

Read More